Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Embolism, Paradoxical”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableUnknownNCT00196027
What this trial is testing

Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism

Who this might be right for
Patent Foramen Ovale
Cierra 40
Post-approval studies (Phase 4)UnknownNCT00166257
What this trial is testing

PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism

Who this might be right for
Embolism, ParadoxicalHeart Septal Defects, Atrial
Foundation for Cardiovascular Research, Zurich 414
Not applicableNo Longer AvailableNCT00583401
What this trial is testing

PFO ACCESS Registry

Who this might be right for
Patent Foramen OvaleStroke
Abbott Medical Devices
Not applicableStudy completedNCT01429948
What this trial is testing

Identification the Cause of Silent Cerebral infarctiON in Healthy Subjects (ICONS)

Who this might be right for
Cerebral Infarction
Samsung Medical Center 581
Large-scale testing (Phase 3)UnknownNCT00201461
What this trial is testing

Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)

Who this might be right for
Patent Foramen OvaleStrokeIschemic Attack, Transient
NMT Medical 900
Testing effectiveness (Phase 2)WithdrawnNCT02378623
What this trial is testing

Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli

Who this might be right for
Patent Foramen OvaleCardiac Implantable Electronic Device
Mayo Clinic